AI assistant
Emergent BioSolutions Inc. — Director's Dealing 2011
Mar 17, 2011
32870_dirs_2011-03-17_c6cfabef-55bf-44c2-9d16-02316c732f53.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2011-03-15
Reporting Person: Keese Kyle (EVP, BioSciences Division)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-03-15 | Common Stock | A | 10598 | — | Acquired | 18759 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-03-15 | Employee stock option (right to buy) | $24.15 | A | 21195 | Acquired | 2018-03-14 | Common Stock (21195) | Direct |
Footnotes
F1: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
F2: These restricted stock units vest in three equal annual installments beginning on the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
F3: Exercisable in three equal installments on March 14, 2012, March 14, 2013 and March 14, 2015.